Global Super Generics Market Research Report 2023

The huge cost of drug development and the time overruns to develop new therapeutics have hindered innovation in the drug research and development space by promoting companies to find alternatives to maintain patent protection for a given brand. Super generics or modified therapeutic entities are an excellent form of a given generic drug molecule, which has better patient compliance and therapeutic effect than existing generic drugs.

The global Super Generics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Super Generics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Super Generics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Super Generics in Hospital Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Super Generics include Sun Pharmaceutical Industries, Meda Pharmaceuticals, Taiwan Liposome Company, Dr. Reddy’s Laboratories, Allergan, Teva Pharmaceutical and Celgene Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Super Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Super Generics.

The Super Generics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Super Generics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Super Generics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Super Generics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Oral

1.2.3 Injectable

1.2.4 Others

1.3 Market by Application

1.3.1 Global Super Generics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Super Generics Market Perspective (2018-2029)

2.2 Super Generics Growth Trends by Region

2.2.1 Global Super Generics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Super Generics Historic Market Size by Region (2018-2023)

2.2.3 Super Generics Forecasted Market Size by Region (2024-2029)

2.3 Super Generics Market Dynamics

2.3.1 Super Generics Industry Trends

2.3.2 Super Generics Market Drivers

2.3.3 Super Generics Market Challenges

2.3.4 Super Generics Market Restraints

3.1 Global Top Super Generics Players by Revenue

3.1.1 Global Top Super Generics Players by Revenue (2018-2023)

3.1.2 Global Super Generics Revenue Market Share by Players (2018-2023)

3.2 Global Super Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Super Generics Revenue

3.4 Global Super Generics Market Concentration Ratio

3.4.1 Global Super Generics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Super Generics Revenue in 2022

3.5 Super Generics Key Players Head office and Area Served

3.6 Key Players Super Generics Product Solution and Service

3.7 Date of Enter into Super Generics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Super Generics Historic Market Size by Type (2018-2023)

4.2 Global Super Generics Forecasted Market Size by Type (2024-2029)

5.1 Global Super Generics Historic Market Size by Application (2018-2023)

5.2 Global Super Generics Forecasted Market Size by Application (2024-2029)

6.1 North America Super Generics Market Size (2018-2029)

6.2 North America Super Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Super Generics Market Size by Country (2018-2023)

6.4 North America Super Generics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Super Generics Market Size (2018-2029)

7.2 Europe Super Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Super Generics Market Size by Country (2018-2023)

7.4 Europe Super Generics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Super Generics Market Size (2018-2029)

8.2 Asia-Pacific Super Generics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Super Generics Market Size by Region (2018-2023)

8.4 Asia-Pacific Super Generics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Super Generics Market Size (2018-2029)

9.2 Latin America Super Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Super Generics Market Size by Country (2018-2023)

9.4 Latin America Super Generics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Super Generics Market Size (2018-2029)

10.2 Middle East & Africa Super Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Super Generics Market Size by Country (2018-2023)

10.4 Middle East & Africa Super Generics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Sun Pharmaceutical Industries

11.1.1 Sun Pharmaceutical Industries Company Detail

11.1.2 Sun Pharmaceutical Industries Business Overview

11.1.3 Sun Pharmaceutical Industries Super Generics Introduction

11.1.4 Sun Pharmaceutical Industries Revenue in Super Generics Business (2018-2023)

11.1.5 Sun Pharmaceutical Industries Recent Development

11.2 Meda Pharmaceuticals

11.2.1 Meda Pharmaceuticals Company Detail

11.2.2 Meda Pharmaceuticals Business Overview

11.2.3 Meda Pharmaceuticals Super Generics Introduction

11.2.4 Meda Pharmaceuticals Revenue in Super Generics Business (2018-2023)

11.2.5 Meda Pharmaceuticals Recent Development

11.3 Taiwan Liposome Company

11.3.1 Taiwan Liposome Company Company Detail

11.3.2 Taiwan Liposome Company Business Overview

11.3.3 Taiwan Liposome Company Super Generics Introduction

11.3.4 Taiwan Liposome Company Revenue in Super Generics Business (2018-2023)

11.3.5 Taiwan Liposome Company Recent Development

11.4 Dr. Reddy’s Laboratories

11.4.1 Dr. Reddy’s Laboratories Company Detail

11.4.2 Dr. Reddy’s Laboratories Business Overview

11.4.3 Dr. Reddy’s Laboratories Super Generics Introduction

11.4.4 Dr. Reddy’s Laboratories Revenue in Super Generics Business (2018-2023)

11.4.5 Dr. Reddy’s Laboratories Recent Development

11.5 Allergan

11.5.1 Allergan Company Detail

11.5.2 Allergan Business Overview

11.5.3 Allergan Super Generics Introduction

11.5.4 Allergan Revenue in Super Generics Business (2018-2023)

11.5.5 Allergan Recent Development

11.6 Teva Pharmaceutical

11.6.1 Teva Pharmaceutical Company Detail

11.6.2 Teva Pharmaceutical Business Overview

11.6.3 Teva Pharmaceutical Super Generics Introduction

11.6.4 Teva Pharmaceutical Revenue in Super Generics Business (2018-2023)

11.6.5 Teva Pharmaceutical Recent Development

11.7 Celgene Corporation

11.7.1 Celgene Corporation Company Detail

11.7.2 Celgene Corporation Business Overview

11.7.3 Celgene Corporation Super Generics Introduction

11.7.4 Celgene Corporation Revenue in Super Generics Business (2018-2023)

11.7.5 Celgene Corporation Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Super Generics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Oral

    Table 3. Key Players of Injectable

    Table 4. Key Players of Others

    Table 5. Global Super Generics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Super Generics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Super Generics Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Super Generics Market Share by Region (2018-2023)

    Table 9. Global Super Generics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Super Generics Market Share by Region (2024-2029)

    Table 11. Super Generics Market Trends

    Table 12. Super Generics Market Drivers

    Table 13. Super Generics Market Challenges

    Table 14. Super Generics Market Restraints

    Table 15. Global Super Generics Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Super Generics Market Share by Players (2018-2023)

    Table 17. Global Top Super Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Super Generics as of 2022)

    Table 18. Ranking of Global Top Super Generics Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Super Generics Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Super Generics Product Solution and Service

    Table 22. Date of Enter into Super Generics Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Super Generics Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Super Generics Revenue Market Share by Type (2018-2023)

    Table 26. Global Super Generics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Super Generics Revenue Market Share by Type (2024-2029)

    Table 28. Global Super Generics Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Super Generics Revenue Market Share by Application (2018-2023)

    Table 30. Global Super Generics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Super Generics Revenue Market Share by Application (2024-2029)

    Table 32. North America Super Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Super Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Super Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Super Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Super Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Super Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Super Generics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Super Generics Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Super Generics Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Super Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Super Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Super Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Super Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Super Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Super Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Sun Pharmaceutical Industries Company Detail

    Table 48. Sun Pharmaceutical Industries Business Overview

    Table 49. Sun Pharmaceutical Industries Super Generics Product

    Table 50. Sun Pharmaceutical Industries Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 51. Sun Pharmaceutical Industries Recent Development

    Table 52. Meda Pharmaceuticals Company Detail

    Table 53. Meda Pharmaceuticals Business Overview

    Table 54. Meda Pharmaceuticals Super Generics Product

    Table 55. Meda Pharmaceuticals Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 56. Meda Pharmaceuticals Recent Development

    Table 57. Taiwan Liposome Company Company Detail

    Table 58. Taiwan Liposome Company Business Overview

    Table 59. Taiwan Liposome Company Super Generics Product

    Table 60. Taiwan Liposome Company Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 61. Taiwan Liposome Company Recent Development

    Table 62. Dr. Reddy’s Laboratories Company Detail

    Table 63. Dr. Reddy’s Laboratories Business Overview

    Table 64. Dr. Reddy’s Laboratories Super Generics Product

    Table 65. Dr. Reddy’s Laboratories Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 66. Dr. Reddy’s Laboratories Recent Development

    Table 67. Allergan Company Detail

    Table 68. Allergan Business Overview

    Table 69. Allergan Super Generics Product

    Table 70. Allergan Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 71. Allergan Recent Development

    Table 72. Teva Pharmaceutical Company Detail

    Table 73. Teva Pharmaceutical Business Overview

    Table 74. Teva Pharmaceutical Super Generics Product

    Table 75. Teva Pharmaceutical Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 76. Teva Pharmaceutical Recent Development

    Table 77. Celgene Corporation Company Detail

    Table 78. Celgene Corporation Business Overview

    Table 79. Celgene Corporation Super Generics Product

    Table 80. Celgene Corporation Revenue in Super Generics Business (2018-2023) & (US$ Million)

    Table 81. Celgene Corporation Recent Development

    Table 82. Research Programs/Design for This Report

    Table 83. Key Data Information from Secondary Sources

    Table 84. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Super Generics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Super Generics Market Share by Type: 2022 VS 2029

    Figure 3. Oral Features

    Figure 4. Injectable Features

    Figure 5. Others Features

    Figure 6. Global Super Generics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Super Generics Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Pharmacies Case Studies

    Figure 9. Retail Pharmacies Case Studies

    Figure 10. Online Pharmacies Case Studies

    Figure 11. Super Generics Report Years Considered

    Figure 12. Global Super Generics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Super Generics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Super Generics Market Share by Region: 2022 VS 2029

    Figure 15. Global Super Generics Market Share by Players in 2022

    Figure 16. Global Top Super Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Super Generics as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Super Generics Revenue in 2022

    Figure 18. North America Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Super Generics Market Share by Country (2018-2029)

    Figure 20. United States Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Super Generics Market Share by Country (2018-2029)

    Figure 24. Germany Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Super Generics Market Share by Region (2018-2029)

    Figure 32. China Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Super Generics Market Share by Country (2018-2029)

    Figure 40. Mexico Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Super Generics Market Share by Country (2018-2029)

    Figure 44. Turkey Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Super Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Sun Pharmaceutical Industries Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 47. Meda Pharmaceuticals Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 48. Taiwan Liposome Company Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 49. Dr. Reddy’s Laboratories Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 50. Allergan Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 51. Teva Pharmaceutical Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 52. Celgene Corporation Revenue Growth Rate in Super Generics Business (2018-2023)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed